The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples

MLA

Sophia Harlid, et al. “The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples.” Mediators of Inflammation, vol. 2017, Jan. 2017. EBSCOhost, https://doi.org/10.1155/2017/4803156.

APA

Sophia Harlid, Robin Myte, & Bethany Van Guelpen. (2017). The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples. Mediators of Inflammation, 2017. https://doi.org/10.1155/2017/4803156

Chicago

Sophia Harlid, Robin Myte, and Bethany Van Guelpen. 2017. “The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples.” Mediators of Inflammation 2017 (January). doi:10.1155/2017/4803156.